A start-up announces its installation south of Toulouse, to produce and market paracetamol from 2025.
:quality(50)/2023/07/07/64a7df4c5fe71_placeholder-36b69ec8.png)
Published
Reading time: 1 min
:quality(50)/2021/10/16/phpyMDNjC.jpg)
The Ipsophène company will set up on the Oncopole site south of Toulouse and plans to market up to 4,000 tonnes of paracetamol by next year, according to information from France Bleu Occitanie, Monday February 19.
The last European paracetamol factory closed in 2009 – due to foreign competition and production costs. Since then, 85% of its active ingredient was imported from Asia or the United States. Establishing its manufacturing in France will thus make it possible to limit, in part, the shortages in the country.
A 28 million euro project
The project, worth 28 million euros, is 15% financed by the Occitanie region (which represents 4.2 million euros), which will therefore benefit from a right of oversight over Ipsophène’s activity. , specifies France Bleu Occitanie.
The president of the start-up Jean Boher has not yet revealed the names of the laboratories which will work with them: “I cannot say that the main French laboratories will be our customers but I can say that we have already signed agreements with different laboratories who are very interested in purchasing our molecule” he explained on the microphone of France Bleu Occitanie.
